Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome

PLoS Neglected Tropical Diseases

Volumn 2, Issue 10, 2008, Pages

  Lan, Nguyen Thi Phuong ^a   Kikuchi, Mihoko ^a   Huong, Vu Thi Que ^b   Ha, Do Quang ^b   Thuy, Tran Thi ^c   Tham, Vo Dinh ^c   Tuan, Ha Manh ^c   Tuong, Vo Van ^d   Nga, Cao Thi Phi ^d   Dat, Tran Van ^d   Oyama, Toshifumi ^a   Morita, Kouichi ^a   Yasunami, Michio ^a   Hirayama, Kenji ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b PASTEUR INSTITUTE   (Viet Nam)

^c Children's Hospital No 2   (Viet Nam)

^d Center for Preventive Medicine   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ADOLESCENT; ALLELE; ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CELLULAR IMMUNITY; CHILD; CODON; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE CONTROL; DISEASE SEVERITY; ETHNICITY; GENE FREQUENCY; GENE IDENTIFICATION; HEMORRHAGIC SHOCK; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; PEDIATRIC HOSPITAL; POPULATION RESEARCH; PRACTICE GUIDELINE; SECONDARY INFECTION; VIET NAM; WORLD HEALTH ORGANIZATION; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PHYSIOLOGY; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; MALE;

EID: 56149090610     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000304     Document Type: Article

References (45)

1. Wagenaar JFP, Mairuhu ATA, van Gorp ECM (2004) Genetic influences on dengue virus infections. Dengue Bulletin 28: 126-134.
2. Chaturvedi U, Nagar R, Shrivastava R (2006) Dengue and dengue haemorrhagic fever: Implications of host genetics. FEMS Immunol Med Mic 47: 155-166.
3. World Health Organization (1997) Dengue hemorrhagic fever: Diagnosis, treatment, prevention, and control. Geneva. pp 1-11.
4. Chaturvedi UC, Nagar R, Shrivastava R (2006) Macrophage and dengue virus: Friend or foe? Indian J Med Res 124: 23-40.
5. World Health Organization (1999) Prevention and control of dengue and dengue hemorrhagic fever: Comprehensive guidelines. WHO Regional publication, SEARO No. 29.
6. Nguyen TKT (2004) Annual report of National program for dengue control in Vietnam.
7. World Health Organization (2005) Dengue, dengue haemorrhagic fever and dengue shock syndrome in the context of the integrated management of childhood illness. WHO/FCH/CAH/05.13.
8. Halstead SB (2007) Dengue. Lancet 370: 1644-52.
9. Suharti C, van Gorp EC, Dolmans WM, Setiati TE, Hack CE, et al. (2003) Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw 14: 172-177.
10. Pang T, Cardosa MJ, Guzman MG (2007) Of cascades and perfect storms: The immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85: 43-45.
11. White NJ (1999) Variation in virulence of dengue virus. Lancet 354: 1401-1402.
12. Loke H, Bethell D, Phuong CXT, Day N, White N, et al. (2002) Susceptibility to dengue hemorrhagic fever in Vietnam: Evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 67: 102-106.
13. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, et al. (2005) A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37: 507-513.
14. King NJ, Shrestha B, Kesson AM (2003) Immune modulation by flaviviruses. Adv Virus Res 60: 121-155.
15. Spaulding AC, Kurane I, Ennis FA, Rothman AL (1999) Analysis of murine C08+T-cell clones specific for the Dengue virus NS3 protein: Flavivirus crossreactivity and influence of infecting serotype. J Virol 73: 398-403.
16. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, et al. (2002) T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 168: 5959-5965.
17. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, et al. (2001) Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: A double-edged sword? J Infect Dis 184: 1369-1373.
18. Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, et al. (2002) HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60: 309-318.
19. José G, Rigau-Pérez (2006) Severe dengue: The need for new case definitions. Lancet Infect Dis 6: 297-302.
20. Innis BL, Nisalak A, Nimmannitva S, Kusalerdchariya S, Chongswasdi V, et al. (1989) An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 40: 418-427.
21. Gubler DJ, Kuno G, Sather GE, Valez M, Oliver A (1984) Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 33: 158-165.
22. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545-551.
23. Charron D (1997) 12th International Histocompatibility Workshop and Conference Proceedings: Genetic Diversity of HLA: Functional and Medical Implications. Ishikawa Y, Tanaka H, Semana G, Tiercy JM, Fan L, Blasczyk R, et al. (1997) 12th AHS#2 report 1. Serves: Medical and Scientific International Publisher. pp 35-41.
24. Butt N, Abbassi A, Munir SM, Ahmad SM, Sheikh QH (2008) Haematological and Biochemical Indicators for the Early Diagnosis of Dengue Viral Infection. J Coll Physicians Surg Pak 18: 282-285.
25. Faridi MM, Aggarwal A, Kumar M, Sarafrazul A (2008) Clinical and biochemical profile of dengue haemorrhagic fever in children in Delhi. Trop Doct 38: 28-30.
26. Díaz-Quijano FA, Martínez-Vega RA, Villar-Centeno LA (2005) Early indicators of severity in dengue virus infection. Enferm Infecc Microbiol Clin 23: 529-532.
27. Pham TB, Nguyen TH, Vu TQ, Nguyen TL, Malvy D (2007) Predictive factors of dengue shock syndrome at the Children hospital No.1, Ho Chi Minh City, Vietnam. Bull Soc Pathol Exot 100: 43-7.
28. Chao DY, Lin TH, Hwang KP, Liu CC, King CC (2004) 1998 dengue hemorrhagic fever in Taiwan. Emer Infect Dis 10: 552-553.
29. Sriprom M, Pongsumpun P, Yoksan S, Barbazan P, Gonzaler JP, et al. (2003) Dengue hemorrhagic fever in Thailand, 1998-2003: Primary or secondary infection. Dengue Bull 27: 39-45.
30. Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, et al. Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored. Emerg Infect Dis 8: 1474-1479.
31. Islam MA, Ahmed MU, Begum N, Chowdhury NA, Khan AH, et al. (2006) Molecular characterization and clinical evaluation of dengue outbreak in 2002 in Bangladesh. Jpn J Infect Dis 59: 85-91.
32. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
33. Paradoa Perez ML, Trujillo Y, Basanta P (1987) Association of dengue hemorrhagic fever with the HLA system; Haematol 20: 83-87.
34. Beatriz Sierra, Roberto Alegre, Ana BPérez, Gissel García, et al. (2007) HLA-A,-B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection. Human Immunol 68: 531-540.
35. Sidney J, Peters B, Frahm N, Brander C, Settle A (2008) HLA class I supertypes: A revised and updated classification. BMC Immunol 9: 1 doi: 10.1186/1471-2172-9-1.
36. Umapathy S, Pawar A, Ghosh K (2007) Specific human leukocyte antigen alleles associated with HIV-1 infection in an Indian population. J Acquir Immune Defic Syndr 44: 489-490.
37. Mathew A, Kurane I, Rothman AL, Zeng LL, Brinton MA, et al. (1996) Dominant recognition by human CD8-cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 98: 1684-1691.
38. Simmons Cp, Doug T, Chau NV, Dung NT, Chau TN, et al. (2005) Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol 79: 5665-5675.
39. Maureen PM, Carrington M (2005) Immunogenetics of viral infections. Curr Opin Immunol 17: 510-516.
40. LaFleur C, Granados J, Vargas-Alarcon G, Ruiz-Morales J, Villarreal-Garza C, et al. (2002) HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol 63: 1039-1044.
41. Charron D (1997) 12th International Histocompatibility Workshop and Conference Proceedings: Genetic Diversity of HLA: Functional and Medical Implications. Clayton J, Lonjou C, eds (1997) Whittle D. Allele and haplotype frequencies for HLA loci in various ethnic groups. Sevres: Medical and Scientific International Publisher. pp 665-775.
42. Burdett L, Smith K, Tu B, Guiterrez M, Buck K, Maiers M, et al. (2003) DRB-DQB1 diversity in the analysis of 4727 donors tested by SBT. Human Immunology 64: S6.
43. Tokushige K, Tsuchiya N, Hasegawa K, Hashimoto E, Yamauchi K, et al. (2003) Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV. Am J Gastroenterol 98: 160-166.
44. Aikawa T, Kojima M, Onishi H, Tamura R, Fukuda S, et al. (1996) HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatic C. J Med Virol 49: 274-278.
45. Chaturvedi UC, Agarwal R, Elbishbish EA, Mustafa AS (2000) Cytokine cascade in dengue hemorrhagic fever: Implications for pathogenesis. FEMS Immunol Med Mic 28: 183-188.